Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovateltide in Acute Spinal Cord Injury
NCT04054414Phase 2Recruiting
- Sponsor
- Pharmazz, Inc.
- Start
- Jan 2019
- Primary completion
- Jun 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sovateltide in spinal cord injury (SCI), sponsored by Pharmazz, Inc.. Started Jan 2019; status: recruiting.
02
Drugs
sovateltide
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT04054414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054414.